R. Kurth

The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic NRG1 Fusions

M. Ladanyi, R. Somwar, E. de Stanchina, 2021, Clinical Cancer Research.

Spontaneous chromosomal breakage and high incidence of leukemia in inherited disease.

T. Schroeder, R. Kurth, R. Kurth, 1971, Blood.

Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations

M. Ladanyi, R. Somwar, E. de Stanchina, 2023, Nature Cancer.